Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Scanfil Q1’25: Share price has reached neutral zone

Scanfil

Scanfil's Q1 report was rather neutral. Revenue decreased by 3% and the negative top-line development was mainly caused by sluggish demand, while the ramp-up of several new projects at various factories also limited sales. The stock is reasonably valued, but the expected return no longer exceeds the sustainable required return. Head of research Antti Viljakainen summarizes.

Read the latest research: Share price has reached neutral zone

Följ oss på:

  • X (Twitter)
  • Instagram
  • TikTok

Du är hjärtligt välkommen att ansluta dig till vår kostnadsfria community och delta i heta aktiediskussioner på forumet.

Cinclus Pharma, Audiocast, Q1'25
2025-05-20 10:00 Cinclus Pharma
Lagercrantz Group, Audiocast with teleconference, Q4'24/25
2025-05-20 10:00 Lagercrantz Group
Relais as an Investment | Investor Day May, 19, 2025
2025-05-19 15:00 Relais Group
Endomines as an Investment | Investor Day May 19, 2025
2025-05-19 15:00 Endomines Finland
Ascelia Pharma - First quarter 2025 highlights
2025-05-19 10:00 Ascelia Pharma
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.